R. Aron English - Nov 13, 2023 Form 4 Insider Report for Anebulo Pharmaceuticals, Inc. (ANEB)

Role
Director, 10%+ Owner
Signature
/s/ Aron R. English
Stock symbol
ANEB
Transactions as of
Nov 13, 2023
Transactions value $
$0
Form type
4
Date filed
12/20/2023, 04:22 PM
Previous filing
Oct 23, 2023
Next filing
Dec 1, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANEB Common Stock Award $0 +300K $0.00 300K Nov 13, 2023 22NW, LP F1, F2, F3
transaction ANEB Common Stock Gift $0 -300K -100% $0.00* 0 Dec 18, 2023 22NW, LP F3
transaction ANEB Common Stock Gift $0 +300K +5.92% $0.00 5.37M Dec 18, 2023 22NW Fund, LP F4
holding ANEB Common Stock 4.65M Nov 13, 2023 Pharma Investors, LLC F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were issued to 22NW, LP as partial consideration for entering into a loan and security agreement with the Issuer.
F2 This Form 4 is filed jointly by Aron R. English, 22NW, LP and 22NW Fund, LP (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock. Each of the Reporting Persons disclaims beneficial ownership of the securities of the Issuer owned directly by other members of the Section 13(d) group and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 or for any other purpose. Further, each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.
F3 Securities owned directly by 22NW, LP. Mr. English, as the Manager of 22NW, LP may be deemed to beneficially own the securities owned directly by 22NW, LP.
F4 Securities owned directly by 22NW Fund, LP. Mr. English, as the Manager of 22NW Fund GP, LLC, which is the General Partner of 22NW Fund, LP, may be deemed to beneficially own the securities owned directly by 22NW Fund, LP.
F5 Securities owned directly by Pharma Investors, LLC. Mr. English, as the owner of Pharma Investors, LLC, may be deemed to beneficially own the securities owned directly by Pharma Investors, LLC.